Company

Seekyo Therapeutics

Biotechnology Research Futuroscope, Fr 7 employees

Employees: 7
Contacts: 3
Emails: 3

seekyo-therapeutics.com LinkedIn Crunchbase

Seekyo Therapeutics Overview

Headquarters: Futuroscope, Fr
Website: seekyo-therapeutics.com
Industry: Biotechnology Research
Employees: 7
Founded: 2018
Funding: 774.7K
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Therapeutic vectors ADC Microenvironment Cancer Oncology Therapeutic vector Smart Molecular System Drug Delivery System in vitro in vivo Life Science Biotechnology

About Seekyo Therapeutics

The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC. Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME). Seekyo’s lead compound SKY01 induces a selective tumor self-destruction: • Efficacy and safety validated in small and large animals (e.g. Dogs). • Unprecedented antitumor efficacy vs. Standards of Care • Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal…) • Low Cost of Goods

Seekyo Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Seekyo Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christian Delaroche	Business-angel, Membre De Badge	Greater Paris Metropolitan Region, France	Email
Oury Chetboun	Founder and CEO @ Seekyo Therapeutics - 🧬 Biotech Leader Driving Breakthroughs in Oncology - 🌐 Board Member & Advisor for Early-stage Growth		View
Laurent Bracco	Consultant Et Investisseur En Sciences De La Vie / Biotechnologies	Greater Paris Metropolitan Region, France	Email
Emmanuel Ventadour	Tech, Cybersecurity - International Growth Strategy & Business Development	San Francisco Bay Area, United States	Email